Korrektur
Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation
Journal of the American Heart Association · 12.11.2026
DOI: 10.1161/jaha.125.045456 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of the American Heart Association, online erschienen am 12.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.045456
Vancouver
Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.045456
BibTeX
@article{euvimed2026,
title = {Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.045456}
}
EUVIMED